Total raised
—
Stage
Pre-Funding
Founded
2018
Headcount
9
HQ
Gan Yavne
Sector
Health Tech & Life Sciences
About
IMCI Pharmaceuticals is a pharma-grade medical cannabis company redefining patient care through science, safety, and precision. Our proprietary NanoVATE™ drug-delivery platform enhances cannabinoid bioavailability, enabling fast, accurate, and long-lasting relief through our iCann product line: iCann Fast, iCann Oral, and iCann LA. With proven clinical results, exclusive IP, and EU-GMP-compliant manufacturing, IMCI is expanding across Europe, Israel, and the U.S., bringing standardized, effective, and stigma-free cannabis treatments to global markets.
🌿 IMCI is Making Medical Cannabis: Safer, Effective, and Patient-Focused
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisDrugs Discovery & Development
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B2CB2B
Highlights
1 PatentsVerified
Tags
oncologydrug-developmentcannabispain-relieftreatmentspain-freetherapeuticsdrug-deliverydrug-discoverypharmaceuticalsbiopharmaceuticalmedical-cannabisbiotechnologycancerchronic-painpharma-companies